GeneDx Holdings Corp.

WGS ·Healthcare, Medical Care Facilities, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $105.0M $85.2M $99.7M $123.9M $400.6M $108.1M
Accounts Receivable $74.4M $37.6M — $42.6M $26.5M $32.0M
Inventory $14.0M $10.7M $8.8M $13.7M $33.5M $25.0M
Total Current Assets $268.3M $198.0M $182.3M $212.6M $483.5M $174.1M
Property, Plant & Equipment $45.7M $32.9M $32.5M $51.5M $62.7M $63.1M
Goodwill $13.5M $0 — — $0 $0
Intangible Assets (Excl. Goodwill) $168.5M $158.6M $172.6M $186.7M $0 —
Total Assets $523.7M $419.4M $418.8M $490.9M $554.1M $251.6M
Liabilities
Accounts Payable $2.5M $8.0M $10.2M $46.0M $44.7M $26.7M
Total Current Liabilities $108.9M $54.8M $58.8M $144.3M $101.3M $73.4M
Long-Term Debt $48.2M $51.9M $52.7M $6.3M $11.0M $19.0M
Total Liabilities $215.5M $174.1M $190.7M $237.2M $166.0M $247.3M
Stockholders' Equity
Retained Earnings $-1.37B $-1.35B $-1.30B $-1.12B $-575.4M $-330.1M
Total Stockholders' Equity $308.2M $245.2M $228.0M $253.7M $388.1M $-330.1M